A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception
- Conditions
- Healthy WomenFemale Contraception
- Interventions
- Biological: levonorgestrel butanoate (LB) injection
- First Posted Date
- 2019-10-29
- Last Posted Date
- 2023-08-15
- Lead Sponsor
- Health Decisions
- Target Recruit Count
- 136
- Registration Number
- NCT04143659
- Locations
- 🇺🇸
Comprehensive Women's Health Center, Denver, Colorado, United States
🇺🇸Eastern Virginia Medical School, Norfolk, Virginia, United States
🇺🇸Boston Medical Center Corporation, Boston, Massachusetts, United States
Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg
- First Posted Date
- 2018-05-25
- Last Posted Date
- 2019-10-08
- Lead Sponsor
- Health Decisions
- Target Recruit Count
- 1200
- Registration Number
- NCT03537768
- Locations
- 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
🇺🇸University of Pittsburgh/Magee Women's Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸Oregon Health Science University, Portland, Oregon, United States
Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men
- Conditions
- HealthyMale ContraceptionMen
- Interventions
- First Posted Date
- 2018-03-06
- Last Posted Date
- 2019-08-12
- Lead Sponsor
- Health Decisions
- Target Recruit Count
- 100
- Registration Number
- NCT03455075
- Locations
- 🇺🇸
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸University of Washington Medical Center & Health Sciences, Seattle, Washington, United States
Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception
- Conditions
- MenHealthyMale Contraception
- Interventions
- First Posted Date
- 2018-03-02
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Health Decisions
- Target Recruit Count
- 420
- Registration Number
- NCT03452111
- Locations
- 🇮🇹
University of Bologna, Italy, Bologna, Italy
🇸🇪Karolinska Institutet, Stockholm, Sweden
🇺🇸University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States
Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring
- First Posted Date
- 2018-02-14
- Last Posted Date
- 2019-05-20
- Lead Sponsor
- Health Decisions
- Target Recruit Count
- 300
- Registration Number
- NCT03432416
- Locations
- 🇺🇸
Essential Access Health, Los Angeles, California, United States
🇺🇸Bellevue Hospital Center, New York, New York, United States
🇺🇸Oregon Health Science University, Portland, Oregon, United States
28-Day Repeat-Dose, Dose Escalation Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men
- Conditions
- Male ContraceptionHealthy Men
- Interventions
- Drug: 11β-methyl-nortestosterone-dodecylcarbonateDrug: Placebo
- First Posted Date
- 2017-10-02
- Last Posted Date
- 2019-08-12
- Lead Sponsor
- Health Decisions
- Target Recruit Count
- 43
- Registration Number
- NCT03298373
- Locations
- 🇺🇸
University of Washington Medical Center & Health Sciences, Seattle, Washington, United States
🇺🇸Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States
Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive
- First Posted Date
- 2017-09-28
- Last Posted Date
- 2019-10-09
- Lead Sponsor
- Health Decisions
- Target Recruit Count
- 300
- Registration Number
- NCT03296098
- Locations
- 🇺🇸
Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States
🇺🇸New York University, School of Medicine, New York, New York, United States
🇺🇸Columbia University, New York, New York, United States
Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males
- Conditions
- Male ContraceptionHealthy MenHealthy WomenProduct Transference
- Interventions
- First Posted Date
- 2016-12-16
- Last Posted Date
- 2018-02-23
- Lead Sponsor
- Health Decisions
- Target Recruit Count
- 12
- Registration Number
- NCT02994602
- Locations
- 🇺🇸
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸University of Washington Medical Center & Health Sciences, Seattle, Washington, United States
Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)
- Conditions
- Healthy MenMale Contraception
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-10-06
- Last Posted Date
- 2021-07-09
- Lead Sponsor
- Health Decisions
- Target Recruit Count
- 84
- Registration Number
- NCT02927210
- Locations
- 🇺🇸
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸University of Washington Medical Center & Health Sciences, Seattle, Washington, United States
Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men
- Conditions
- Healthy MenMale Contraception
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2019-08-12
- Lead Sponsor
- Health Decisions
- Target Recruit Count
- 12
- Registration Number
- NCT02754687
- Locations
- 🇺🇸
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸University of Washington, Seattle, Washington, United States